Free Trial

FY2026 EPS Estimates for AMPX Decreased by Analyst

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Northland Securities cut its FY2026 EPS estimate for Amprius Technologies to -$0.10 per share from -$0.08, a more bearish view than the current consensus of -$0.06.
  • The company recently missed quarterly EPS expectations, reporting -$0.04 per share versus an estimated -$0.02, though revenue of $28.54 million came in above forecasts.
  • Despite the near-term earnings pressure, Wall Street sentiment remains mostly constructive: eight analysts rate AMPX a Buy, one a Sell, and the consensus target price is $20.25.
  • Five stocks to consider instead of Amprius Technologies.

Amprius Technologies, Inc. (NYSE:AMPX - Free Report) - Stock analysts at Northland Securities decreased their FY2026 earnings estimates for shares of Amprius Technologies in a research report issued to clients and investors on Monday, May 11th. Northland Securities analyst T. Jackson now forecasts that the company will earn ($0.10) per share for the year, down from their previous estimate of ($0.08). The consensus estimate for Amprius Technologies' current full-year earnings is ($0.06) per share. Northland Securities also issued estimates for Amprius Technologies' FY2029 earnings at $0.30 EPS and FY2030 earnings at $0.43 EPS.

Amprius Technologies (NYSE:AMPX - Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%. The business had revenue of $28.54 million for the quarter, compared to analysts' expectations of $25.72 million.

Several other analysts have also recently issued reports on the stock. B. Riley Financial upped their price objective on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, March 9th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research note on Monday, April 20th. Wall Street Zen cut shares of Amprius Technologies from a "hold" rating to a "sell" rating in a research note on Saturday. Cantor Fitzgerald upped their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a research note on Friday, March 6th. Finally, William Blair reaffirmed an "outperform" rating on shares of Amprius Technologies in a research note on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $20.25.

Read Our Latest Stock Analysis on AMPX

Amprius Technologies Trading Up 6.6%

Shares of NYSE AMPX opened at $18.84 on Wednesday. Amprius Technologies has a 12-month low of $2.34 and a 12-month high of $22.80. The stock has a market cap of $2.58 billion, a PE ratio of -62.80 and a beta of 2.20. The company has a 50-day moving average of $17.93 and a 200 day moving average of $13.36.

Institutional Trading of Amprius Technologies

Hedge funds have recently made changes to their positions in the company. KBC Group NV purchased a new position in shares of Amprius Technologies during the 1st quarter worth approximately $57,000. Quarry LP purchased a new position in shares of Amprius Technologies during the 3rd quarter worth approximately $42,000. Jones Financial Companies Lllp boosted its position in shares of Amprius Technologies by 353.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company's stock worth $50,000 after purchasing an additional 3,532 shares during the period. Parallel Advisors LLC purchased a new position in shares of Amprius Technologies during the 3rd quarter worth approximately $54,000. Finally, Leonteq Securities AG purchased a new position in shares of Amprius Technologies during the 4th quarter worth approximately $47,000. Hedge funds and other institutional investors own 5.04% of the company's stock.

Insider Activity

In other news, Director Steven Chu sold 155,565 shares of the stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $18.50, for a total value of $2,877,952.50. Following the completion of the sale, the director owned 127,339 shares of the company's stock, valued at $2,355,771.50. This represents a 54.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CTO Constantin Ionel Stefan sold 25,366 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total transaction of $257,718.56. Following the completion of the sale, the chief technology officer directly owned 723,330 shares of the company's stock, valued at approximately $7,349,032.80. This trade represents a 3.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 2,539,829 shares of company stock worth $42,323,376. Corporate insiders own 5.10% of the company's stock.

More Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

See Also

Earnings History and Estimates for Amprius Technologies (NYSE:AMPX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines